Hypopharyngeal cancer often coexists with other primary cancers, particularly esophageal cancer. Making a treatment choice for patients with synchronous double cancer may be difficult, and the treatment may not be performed as scheduled. We examined 152 patients with hypopharyngeal cancer receiving first-line therapy in our hospital from January 2011 to December 2014. Eighty-four patients had double cancer (55%) , and the most